Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9GJS

ERAP1 in complex with 1-[2-(6-bromo-3-oxo-3,4-dihydro-2H-1,4-benzoxazin-4-yl)acetamido]-4,4-difluorocyclohexane-1-carboxylic acid

これはPDB形式変換不可エントリーです。
9GJS の概要
エントリーDOI10.2210/pdb9gjs/pdb
分子名称Endoplasmic reticulum aminopeptidase 1, ZINC ION, PHOSPHATE ION, ... (6 entities in total)
機能のキーワードerap1, peptide binding protein
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数1
化学式量合計106893.63
構造登録者
Rowland, P. (登録日: 2024-08-22, 公開日: 2025-01-22)
主引用文献Hryczanek, R.P.,Hackett, A.S.,Rowland, P.,Chung, C.W.,Convery, M.A.,Holmes, D.S.,Hutchinson, J.P.,Kitchen, S.,Korczynska, J.,Law, R.P.,Lea, J.D.,Liddle, J.,Lonsdale, R.,Neu, M.,Nickels, L.,Phillipou, A.,Rowedder, J.E.,Schneck, J.L.,Scott-Stevens, P.,Sheehan, H.,Tayler, C.L.,Temponeras, I.,Tinworth, C.P.,Walker, A.L.,Wojno-Picon, J.,Young, R.J.,Lindsay, D.M.,Stratikos, E.
Optimization of Potent and Selective Cyclohexyl Acid ERAP1 Inhibitors Using Structure- and Property-Based Drug Design.
Acs Med.Chem.Lett., 15:2107-2114, 2024
Cited by
PubMed Abstract: Endoplasmic reticulum aminopeptidase 1 (ERAP1) cleaves the -terminal amino acids of peptides, which can then bind onto major histocompatibility class I (MHC-I) molecules for presentation onto the cell surface, driving the activation of adaptive immune responses. In cancer, overtrimming of mature antigenic peptides can reduce cytotoxic T-cell responses, and ERAP1 can generate self-antigenic peptides which contribute to autoimmune cellular responses. Therefore, modulation of ERAP1 activity has potential therapeutic indications for cancer immunotherapy and in autoimmune disease. Herein we describe the hit-to-lead optimization of a series of cyclohexyl acid ERAP1 inhibitors, found by X-ray crystallography to bind at an allosteric regulatory site. Structure-based drug design enabled a >1,000-fold increase in ERAP1 enzymatic and cellular activity, resulting in potent and selective tool molecules. For lead compound , rat pharmacokinetic properties showed moderate unbound clearance and oral bioavailability, thus highlighting the promise of the series for further optimization.
PubMed: 39691536
DOI: 10.1021/acsmedchemlett.4c00401
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.351 Å)
構造検証レポート
Validation report summary of 9gjs
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon